Latest Breaking News On - Combat casualty care research program - Page 1 : vimarsana.com

Nexalin Technology Announces Poster Presentation at State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment -March 13, 2024 at 08:31 am EDT

Nexalin Technology Announces Poster Presentation at State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment -March 13, 2024 at 08:31 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNexalin genMark whiteUs army medical researchBiomedical advanced researchExchange commissionCrescendo communicationsWaltere washington convention centerNexalin technologyDevelopment commandTechnology meetingDevelopment authorityCompany or nexalin nasdaqNexalin technology incNational medical products administrationCasualty care research program

Research shows U S ability to treat patients who require blood on any given day in peril

Alarmingly inadequate supply of blood, economic disparity and logistics among many factors playing a role in fueling shortage. Written by: Rosalind Fournier Media contact: Anna Jones The number of blood donors is at an a.

United statesFort detrickAmerican red crossJody potterholcombAnna jonesRosalind fournierJohnb holcombTravis polkUniversity of alabama at birminghamdivision traumaJournal of the american medicine associationCasualty care research programDepartment of defenseUs army medical researchUniversity of texas medical school at houstonTrauma consultant for the army surgeonAmerican red

College athletes experience worse post-injury outcomes for concussions suffered outside of sports

College athletes experience worse post-injury outcomes for concussions suffered outside of sports
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Patricia robyDepartment of defenseTraumatic brain injury program under award noOffice of theAlliance concussion assessmentDepartment of defense concussion assessmentProgram committeeMinds matter concussion programStroke of the national institutes healthHealth affairsCasualty care research program psychological healthCasualty care research programNational collegiate athletic associationNational institute of neurologic disordersDefense concussion assessmentNational institute

Ischemix, Inc Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury

CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translati.

David dewahlDavida dewahl jrIschemix incAltasciences company incHealth affairsUs army medical researchDepartment of defense contact informationTechnology enterprise consortium under award noDepartment of defenseDevelopment commandCasualty care research programNeurotrauma at combat casualty care research programTechnology enterprise consortiumTechnology internationalPrincipal investigatorChief medical officer

Ischemix, Inc Completes Successful Phase 1 Trial of Novel Compound

Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound .

David dewahlDavida dewahl jrHealth affairsUs army medical researchNeurotrauma at combat casualty care research programIschemix incDevelopment commandTechnology enterprise consortiumCasualty care research programTechnology internationalNews networkTechnology enterprise consortium under award noAltasciences company incDepartment of defensePrincipal investigatorChief medical officer